Targeted therapy with gefitinib or erlotinib for 2 years is better than chemotherapy as adjuvant in resected non small cell lung cancer stage l to llla with EGFR mutation. The result suggest better disease free survival, however overall survival data

Few important clinical pearls in Stage III NSCLC!Stage III NSCLC is a heterogeneous disease and carefully selected patients have better survival when surgery is integrated as a part of multimodality treatment approach.MRI brain with contrast shou

Question- Is it possible to cure CML (CHRONIC MYELOID LEUKEMIA) one of the types of blood cancer with tablets (bcr-abl kinase inhibitor) eg imatinib, nilotinib or dasatinib?Answer- We don’t know the answer yet, but studies are now looking for stoppi

CML (chronic myeloid leukemia) is a cancer that affects bone marrow and blood.The diagnosis of CML is confirmed by presence of Philadelphia chromosome on cytogenetics or FISH or by detecting bcr-abl by PCR.It has 3 phases chronic, accelerated and b

A awareness video on Head and Neck Cancers:https://youtu.be/NiAvJGozF8A

Pregnancy and cancer: A challenge for obstetrician and oncologist!As the age of child birth is delayed we may be seeing more cases with cancer in pregnancy.At present estimated incidence of cancer in pregnancy is estimated to be around 1 in 1000

Happy to share our article- "MRD negative CR after azacitidine and venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT" published in the international journal, Leukemia Research Reports.article link:https://doi.or

Breast cancer can be diagnosed at an early stage when clinical breast examination is performed at regular intervals. Clinical breast examination can reduce deaths due to breast cancer and it is a good strategy for early diagnosis of breast cancer in